Neurology & Neurovascular

Neuromodulation, neurovascular, and neurosurgical devices collectively make up iData’s U.S. neurological devices market report. Within the United States, the overall neurological device market is growing and our analysts expect it to continue the substantial growth pattern into 2026. The categories included within the U.S. neurological device market report include:  Cerebrospinal Fluid Management  Interventional Neuroradiology  Neuromodulation 

Medtronic recently announced the three-month results from a large, multicenter randomized controlled trial (RT) showing statistically significant and superior back pain relief through Differential Target Multiplexed (DTM™) Spinal Cord Stimulation (SCS) compared to conventional SCS. Both therapies were evaluated using the Intellis™ neurostimulator. The trials began on the hypothesis of: Do glial and neuronal cells

Register to receive a free Global Neurological Devices Market Analysis, Size, and Trends Report synopsis and brochure. In a new submission to the FDA, Medtronic has presented its InterStim Micro neurostimulator and InterStim SureScan MRI leads into the neuromodulation device market for pre-market approval (PMA). The device is 80% smaller than what is currently in